Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 4
2009 2
2011 1
2012 1
2013 1
2014 1
2015 2
2016 1
2017 5
2018 2
2019 1
2021 2
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations.
Bodini M, Ronchini C, Giacò L, Russo A, Melloni GE, Luzi L, Sardella D, Volorio S, Hasan SK, Ottone T, Lavorgna S, Lo-Coco F, Candoni A, Fanin R, Toffoletti E, Iacobucci I, Martinelli G, Cignetti A, Tarella C, Bernard L, Pelicci PG, Riva L. Bodini M, et al. Among authors: toffoletti e. Blood. 2015 Jan 22;125(4):600-5. doi: 10.1182/blood-2014-05-576157. Epub 2014 Dec 12. Blood. 2015. PMID: 25499761 Free PMC article. Review.
Expression and modulation of S100A4 protein by human mast cells.
Domenis R, Pilutti D, Orsaria M, Marzinotto S, Candotti V, Bosisio G, Bulfoni M, Ruaro ME, Di Loreto C, Mea VD, Toffoletti E, Londero AP, Mariuzzi L, Gri G. Domenis R, et al. Among authors: toffoletti e. Cell Immunol. 2018 Oct;332:85-93. doi: 10.1016/j.cellimm.2018.08.001. Epub 2018 Aug 4. Cell Immunol. 2018. PMID: 30097176
BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment-free remission: A study from the "GRUPPO TRIVENETO LMC".
Di Giusto S, Toffoletti E, Bonifacio M, Binotto G, Miggiano MC, Calistri E, Stulle M, Ermacora A, Stella R, Scaffidi L, D'Amore F, Scotton G, Griguolo D, De Matteis G, Bertorelle R, Krampera M, Semenzato G, Fanin R, Damiani D, Tiribelli M. Di Giusto S, et al. Among authors: toffoletti e. Cancer Med. 2023 Feb;12(3):3180-3184. doi: 10.1002/cam4.5158. Epub 2022 Oct 8. Cancer Med. 2023. PMID: 36208021 Free PMC article.
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation.
Bernardi S, Malagola M, Zanaglio C, Polverelli N, Dereli Eke E, D'Adda M, Farina M, Bucelli C, Scaffidi L, Toffoletti E, Deambrogi C, Stagno F, Bergamaschi M, Franceschini L, Abruzzese E, Divona MD, Gobbi M, Di Raimondo F, Gaidano G, Tiribelli M, Bonifacio M, Cattaneo C, Iurlo A, Russo D. Bernardi S, et al. Among authors: toffoletti e. Cancer Med. 2019 May;8(5):2041-2055. doi: 10.1002/cam4.2087. Epub 2019 Apr 4. Cancer Med. 2019. PMID: 30950237 Free PMC article.
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias.
Montecchini O, Braidotti S, Franca R, Zudeh G, Boni C, Sorio C, Toffoletti E, Rabusin M, Tommasini A, Decorti G, Stocco G. Montecchini O, et al. Among authors: toffoletti e. Front Pharmacol. 2021 Nov 19;12:749361. doi: 10.3389/fphar.2021.749361. eCollection 2021. Front Pharmacol. 2021. PMID: 34867354 Free PMC article.
JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response.
Tosoni L, Fabbro D, Pizzano U, Mullai R, Morelli G, Franzoni A, Damante G, Toffoletti E, Damiani D, Fanin R, Tiribelli M. Tosoni L, et al. Among authors: toffoletti e. Ann Hematol. 2023 May;102(5):1279-1280. doi: 10.1007/s00277-023-05187-5. Epub 2023 Mar 22. Ann Hematol. 2023. PMID: 36947213 No abstract available.
23 results